Portfolio Holdings Detail for ISIN IE00BF4RFH31
| Stock Name / Fund | iShares MSCI World Small Cap UCITS ETF USD (Acc) |
| Issuer | Blackrock |
| Entity holding fund | iShares III Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300PZLRJB7M8H1057 |
| ETF Ticker | WSML(USD) LSE |
| ETF Ticker | WLDS(GBP) LSE |
| ETF Ticker | IUSN(EUR) F |
| ETF Ticker | IUSN.DE(EUR) CXE |
| ETF Ticker | WLDS.LS(GBP) CXE |
| ETF Ticker | WSML.LS(USD) CXE |
| ETF Ticker | WSML.L(GBP) LSE |
| ETF Ticker | WLDS.L(GBP) LSE |
Holdings detail for PCRX
| Stock Name | Pacira BioSciences, Inc. |
| Ticker | PCRX(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US6951271005 |
Show aggregate PCRX holdings
News associated with PCRX
- Pacira BioSciences, Inc. (NASDAQ:PCRX) Given Consensus Recommendation of “Moderate Buy” by Brokerages
- Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Free Report) has earned a consensus rating of “Moderate Buy” from the six ratings firms that are currently covering the company, MarketBeat reports. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 1-year target price […] - 2025-08-12 04:43:07
- Pacira BioSciences, Inc. (NASDAQ:PCRX) Shares Purchased by Zurcher Kantonalbank Zurich Cantonalbank
- Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 20.8% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 16,519 shares of the company’s stock after buying an additional 2,848 shares during […] - 2025-08-08 04:56:50
- Pacira BioSciences (NASDAQ:PCRX) Upgraded at Truist Financial
- Truist Financial upgraded shares of Pacira BioSciences (NASDAQ:PCRX – Free Report) from a hold rating to a buy rating in a research report sent to investors on Friday, MarketBeat.com reports. The brokerage currently has $30.00 target price on the stock. Other equities analysts also recently issued research reports about the stock. HC Wainwright upped their […] - 2025-07-28 04:18:52
- Bank of New York Mellon Corp Has $9.60 Million Stock Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)
- Bank of New York Mellon Corp decreased its position in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 2.6% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 386,149 shares of the company’s stock after selling 10,250 shares during the period. Bank […] - 2025-07-22 06:22:51
- Louisiana State Employees Retirement System Cuts Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)
- Louisiana State Employees Retirement System lessened its stake in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 2.7% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 21,700 shares of the company’s stock after selling 600 shares during the quarter. Louisiana State Employees Retirement System’s holdings in Pacira […] - 2025-07-21 05:18:53
- Illinois Municipal Retirement Fund Has $629,000 Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)
- Illinois Municipal Retirement Fund grew its position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 24.7% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 25,318 shares of the company’s stock after acquiring an additional 5,011 […] - 2025-07-03 05:13:03
- Robeco Institutional Asset Management B.V. Purchases 12,750 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)
- Robeco Institutional Asset Management B.V. increased its position in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 18.2% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 82,694 shares of the company’s stock after buying an additional 12,750 shares during the quarter. Robeco […] - 2025-07-02 05:11:08
- Pacira BioSciences, Inc. (NASDAQ:PCRX) Given Average Recommendation of “Hold” by Brokerages
- Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Free Report) have been assigned an average rating of “Hold” from the nine research firms that are currently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, four have assigned a hold rating and four have issued a buy rating […] - 2025-06-18 05:08:55
- Head to Head Analysis: Pacira BioSciences (NASDAQ:PCRX) versus I-Mab (NASDAQ:IMAB)
- Pacira BioSciences (NASDAQ:PCRX – Get Free Report) and I-Mab (NASDAQ:IMAB – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, institutional ownership, risk, earnings and analyst recommendations. Insider and Institutional Ownership 99.7% of Pacira BioSciences […] - 2025-06-18 03:08:45
- California State Teachers Retirement System Has $812,000 Stock Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)
- California State Teachers Retirement System lessened its holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 1.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 43,123 shares of the company’s stock after selling 835 shares during the quarter. California State Teachers […] - 2025-06-11 05:02:51
- Friday's ETF with Unusual Volume: XPH
- The SPDR S&P Pharmaceuticals ETF is seeing unusually high volume in afternoon trading Friday, with over 318,000 shares traded versus three month average volume of about 57,000. Shares of XPH were up about 1.5% on the day.
Components of that ETF with the highest volume on - 2025-06-06 13:49:47
- Two Sigma Investments LP Acquires 45,222 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)
- Two Sigma Investments LP grew its position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 65.1% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 114,682 shares of the company’s stock after buying an additional 45,222 shares during the quarter. Two Sigma Investments LP’s holdings in Pacira BioSciences were worth […] - 2025-06-02 05:08:57
- State of Wyoming Boosts Stock Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)
- State of Wyoming lifted its position in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 8.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,566 shares of the company’s stock after purchasing an additional 487 shares during the quarter. State of Wyoming’s holdings […] - 2025-05-27 05:17:01
- Graham Capital Management L.P. Sells 61,645 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)
- Graham Capital Management L.P. decreased its holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 83.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 12,268 shares of the company’s stock after selling 61,645 shares during the period. Graham Capital Management […] - 2025-05-19 05:27:01
- Pacira BioSciences, Inc. (NASDAQ:PCRX) Shares Sold by Voya Investment Management LLC
- Voya Investment Management LLC lowered its stake in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 68.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 13,948 shares of the company’s stock after selling 29,901 shares during the quarter. Voya Investment Management […] - 2025-05-13 05:20:57
- MetLife Investment Management LLC Acquires 1,471 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)
- MetLife Investment Management LLC grew its stake in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 5.6% in the 4th quarter, Holdings Channel.com reports. The fund owned 27,883 shares of the company’s stock after purchasing an additional 1,471 shares during the quarter. MetLife Investment Management LLC’s holdings in Pacira BioSciences were worth $525,000 as of […] - 2025-05-06 05:01:05
- Marshall Wace LLP Has $803,000 Stake in Pacira BioSciences, Inc. (NASDAQ:PCRX)
- Marshall Wace LLP lessened its stake in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 91.9% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 42,613 shares of the company’s stock after selling 482,336 shares during the period. Marshall Wace LLP’s holdings in […] - 2025-05-01 04:50:59
- Legal & General Group Plc Sells 1,115 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)
- Legal & General Group Plc decreased its stake in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 0.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 125,849 shares of the company’s stock after selling 1,115 shares during the period. […] - 2025-04-25 05:08:57
- Pacira BioSciences Announces Repurchase Authorization
- (RTTNews) - Pacira BioSciences (PCRX) said its Board of Directors has authorized a share repurchase program of up to an aggregate of $300 million with respect to the common stock, replacing the prior authorization. The share repurchase authorization expires at the end of December - 2025-04-18 04:29:04
- Sei Investments Co. Has $281,000 Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)
- Sei Investments Co. trimmed its stake in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 32.6% in the fourth quarter, HoldingsChannel reports. The firm owned 14,927 shares of the company’s stock after selling 7,231 shares during the period. Sei Investments Co.’s holdings in Pacira BioSciences were worth $281,000 as of its most recent SEC filing. […] - 2025-04-11 04:42:54
- Wellington Management Group LLP Has $8.86 Million Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)
- Wellington Management Group LLP lifted its position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 3.4% during the 4th quarter, Holdings Channel.com reports. The firm owned 470,191 shares of the company’s stock after purchasing an additional 15,542 shares during the quarter. Wellington Management Group LLP’s holdings in Pacira BioSciences were worth $8,858,000 […] - 2025-04-10 05:29:03
- Pacira BioSciences (NASDAQ:PCRX) Shares Gap Up on Analyst Upgrade
- Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Free Report) gapped up prior to trading on Tuesday after HC Wainwright raised their price target on the stock from $48.00 to $65.00. The stock had previously closed at $22.91, but opened at $27.60. HC Wainwright currently has a buy rating on the stock. Pacira BioSciences shares last traded […] - 2025-04-10 02:24:54
- Corebridge Financial Inc. Reduces Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)
- Corebridge Financial Inc. lowered its stake in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 7.2% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 24,412 shares of the company’s stock after selling 1,904 shares during the period. Corebridge Financial Inc.’s holdings in Pacira BioSciences were worth $460,000 as of its most recent filing […] - 2025-04-09 05:27:01
- Arrowstreet Capital Limited Partnership Sells 505,307 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)
- Arrowstreet Capital Limited Partnership cut its stake in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 43.8% during the 4th quarter, Holdings Channel.com reports. The fund owned 647,318 shares of the company’s stock after selling 505,307 shares during the period. Arrowstreet Capital Limited Partnership’s holdings in Pacira BioSciences were worth $12,195,000 as of […] - 2025-04-06 05:26:57
- Thrivent Financial for Lutherans Has $672,000 Stake in Pacira BioSciences, Inc. (NASDAQ:PCRX)
- Thrivent Financial for Lutherans reduced its holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 1.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 35,689 shares of the company’s stock after selling 534 shares during the period. Thrivent Financial for Lutherans’ holdings […] - 2025-04-03 04:16:46
- Prudential Financial Inc. Decreases Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)
- Prudential Financial Inc. reduced its position in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 42.8% in the 4th quarter, HoldingsChannel.com reports. The firm owned 254,168 shares of the company’s stock after selling 190,286 shares during the period. Prudential Financial Inc.’s holdings in Pacira BioSciences were worth $4,789,000 at the end of the most recent […] - 2025-04-01 05:34:48
- Amundi Purchases 15,431 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)
- Amundi raised its position in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 200.8% in the 4th quarter, Holdings Channel reports. The firm owned 23,114 shares of the company’s stock after buying an additional 15,431 shares during the period. Amundi’s holdings in Pacira BioSciences were worth $429,000 at the end of the most recent quarter. […] - 2025-03-21 05:59:07
- Victory Capital Management Inc. Reduces Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)
- Victory Capital Management Inc. trimmed its holdings in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 22.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 94,750 shares of the company’s stock after selling 27,478 shares during the quarter. Victory Capital […] - 2025-03-18 05:41:07
- Illinois Municipal Retirement Fund Has $383,000 Stake in Pacira BioSciences, Inc. (NASDAQ:PCRX)
- Illinois Municipal Retirement Fund reduced its holdings in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 29.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 20,307 shares of the company’s stock after selling 8,510 shares during the period. […] - 2025-03-05 08:01:50
- Principal Financial Group Inc. Has $4.86 Million Stock Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)
- Principal Financial Group Inc. boosted its holdings in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 4.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 257,733 shares of the company’s stock after buying an additional 10,306 shares during the quarter. Principal […] - 2025-03-04 06:14:50
iShares MSCI World Small Cap UCITS ETF USD (Acc) PCRX holdings
| Date | Number of PCRX Shares Held | Base Market Value of PCRX Shares | Local Market Value of PCRX Shares | Change in PCRX Shares Held | Change in PCRX Base Value | Current Price per PCRX Share Held | Previous Price per PCRX Share Held |
|---|
| 2025-11-27 (Thursday) | 34,448 | USD 820,207 | USD 820,207 | 0 | USD 0 | USD 23.81 | USD 23.81 |
| 2025-11-26 (Wednesday) | 34,448 | USD 820,207 | USD 820,207 | -68 | USD 20,471 | USD 23.81 | USD 23.17 |
| 2025-11-25 (Tuesday) | 34,516 | USD 799,736 | USD 799,736 | 0 | USD 345 | USD 23.17 | USD 23.16 |
| 2025-11-24 (Monday) | 34,516 | USD 799,391 | USD 799,391 | 0 | USD 3,797 | USD 23.16 | USD 23.05 |
| 2025-11-21 (Friday) | 34,516 | USD 795,594 | USD 795,594 | 0 | USD 8,629 | USD 23.05 | USD 22.8 |
| 2025-11-20 (Thursday) | 34,516 | USD 786,965 | USD 786,965 | 225 | USD -47,335 | USD 22.8 | USD 24.33 |
| 2025-11-19 (Wednesday) | 34,291 | USD 834,300 | USD 834,300 | 2,250 | USD 52,820 | USD 24.33 | USD 24.39 |
| 2025-11-18 (Tuesday) | 32,041 | USD 781,480 | USD 781,480 | 0 | USD 16,341 | USD 24.39 | USD 23.88 |
| 2025-11-17 (Monday) | 32,041 | USD 765,139 | USD 765,139 | 0 | USD 3,204 | USD 23.88 | USD 23.78 |
| 2025-11-14 (Friday) | 32,041 | USD 761,935 | USD 761,935 | -268 | USD -1,204 | USD 23.78 | USD 23.62 |
| 2025-11-13 (Thursday) | 32,309 | USD 763,139 | USD 763,139 | 0 | USD -7,754 | USD 23.62 | USD 23.86 |
| 2025-11-12 (Wednesday) | 32,309 | USD 770,893 | USD 770,893 | 0 | USD -8,400 | USD 23.86 | USD 24.12 |
| 2025-11-11 (Tuesday) | 32,309 | USD 779,293 | USD 779,293 | 0 | USD 33,924 | USD 24.12 | USD 23.07 |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of PCRX by Blackrock for IE00BF4RFH31
Show aggregate share trades of PCRX| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-11-26 | SELL | -68 | 24.180 | 23.140 | 23.244 | USD -1,581 | 22.74 Loss of -34 on sale |
| 2025-11-26 | SELL | -68 | 24.180 | 23.140 | 23.244 | USD -1,581 | 22.74 Loss of -34 on sale |
| 2025-11-20 | BUY | 225 | | | 22.800* | | 22.74 |
| 2025-11-19 | BUY | 2,250 | | | 24.330* | | 22.73 |
| 2025-11-14 | SELL | -268 | 23.980 | 23.260 | 23.332 | USD -6,253 | 22.71 Loss of -166 on sale |
| 2025-10-29 | BUY | 134 | 21.010 | 21.460 | 21.415 | USD 2,870 | 22.74 |
| 2025-10-21 | BUY | 268 | 22.020 | 22.880 | 22.794 | USD 6,109 | 22.77 |
| 2025-10-07 | BUY | 134 | 23.620 | 24.000 | 23.962 | USD 3,211 | 22.76 |
| 2025-09-08 | SELL | -264 | 26.740 | 26.810 | 26.803 | USD -7,076 | 22.64 Loss of -1,099 on sale |
| 2025-08-15 | BUY | 132 | 24.780 | 25.180 | 25.140 | USD 3,318 | 22.63 |
| 2025-07-14 | BUY | 268 | 23.310 | 23.360 | 23.355 | USD 6,259 | 22.62 |
| 2025-06-30 | BUY | 268 | 23.900 | 24.230 | 24.197 | USD 6,485 | 22.59 |
| 2025-06-25 | BUY | 396 | 23.910 | 24.500 | 24.441 | USD 9,679 | 22.57 |
| 2025-06-20 | SELL | -67 | 24.230 | 24.330 | 24.320 | USD -1,629 | 22.54 Loss of -120 on sale |
| 2025-06-12 | SELL | -536 | 24.450 | 24.590 | 24.576 | USD -13,173 | 22.47 Loss of -1,130 on sale |
| 2025-06-02 | BUY | 201 | 26.240 | 26.430 | 26.411 | USD 5,309 | 22.28 |
| 2025-05-28 | BUY | 134 | 25.560 | 25.980 | 25.938 | USD 3,476 | 22.20 |
| 2025-05-14 | BUY | 67 | 24.450 | 24.900 | 24.855 | USD 1,665 | 21.93 |
| 2025-05-13 | BUY | 134 | 23.400 | 25.210 | 25.029 | USD 3,354 | 21.92 |
| 2025-05-07 | BUY | 201 | 25.180 | 25.400 | 25.378 | USD 5,101 | 21.81 |
| 2025-04-28 | BUY | 66 | 27.140 | 27.180 | 27.176 | USD 1,794 | 21.54 |
| 2025-04-16 | BUY | 871 | 24.470 | 24.980 | 24.929 | USD 21,713 | 21.27 |
| 2025-04-14 | BUY | 134 | 24.970 | 25.350 | 25.312 | USD 3,392 | 21.21 |
| 2025-04-08 | SELL | -134 | 26.270 | 27.640 | 27.503 | USD -3,685 | 21.06 Loss of -863 on sale |
| 2025-04-04 | SELL | -136 | 23.100 | 24.030 | 23.937 | USD -3,255 | 21.02 Loss of -397 on sale |
| 2025-03-28 | BUY | 670 | 24.910 | 25.880 | 25.783 | USD 17,275 | 20.87 |
| 2025-03-12 | SELL | -136 | 22.040 | 23.410 | 23.273 | USD -3,165 | 20.47 Loss of -382 on sale |
| 2025-03-04 | SELL | -136 | 23.530 | 24.020 | 23.971 | USD -3,260 | 20.29 Loss of -500 on sale |
| 2025-02-26 | SELL | -272 | 25.480 | 26.690 | 26.569 | USD -7,227 | 20.08 Loss of -1,766 on sale |
| 2025-02-13 | BUY | 68 | 26.530 | 27.270 | 27.196 | USD 1,849 | 19.35 |
| 2025-02-12 | BUY | 276 | 27.130 | 27.300 | 27.283 | USD 7,530 | 19.23 |
| 2025-01-27 | BUY | 68 | 25.660 | 25.770 | 25.759 | USD 1,752 | 17.73 |
| 2025-01-23 | BUY | 68 | 23.330 | 23.510 | 23.492 | USD 1,597 | 17.50 |
| 2024-12-09 | BUY | 2,556 | 19.090 | 19.810 | 19.738 | USD 50,450 | 17.22 |
| 2024-12-04 | BUY | 142 | 19.090 | 19.490 | 19.450 | USD 2,762 | 17.11 |
| 2024-12-03 | BUY | 213 | 16.680 | 17.940 | 17.814 | USD 3,794 | 17.11 |
| 2024-11-19 | BUY | 432 | 16.730 | 16.910 | 16.892 | USD 7,297 | 17.12 |
| 2024-11-18 | BUY | 144 | 16.640 | 16.820 | 16.802 | USD 2,419 | 17.14 |
| 2024-11-12 | BUY | 280 | 16.800 | 17.540 | 17.466 | USD 4,890 | 17.15 |
| 2024-11-11 | BUY | 70 | 17.500 | 17.870 | 17.833 | USD 1,248 | 17.13 |
| 2024-11-11 | BUY | 70 | 17.500 | 17.870 | 17.833 | USD 1,248 | 17.13 |
| 2024-11-07 | BUY | 345 | 17.700 | 18.220 | 18.168 | USD 6,268 | 17.07 |
| 2024-11-07 | BUY | 345 | 17.700 | 18.220 | 18.168 | USD 6,268 | 17.07 |
| 2024-10-23 | BUY | 138 | 17.380 | 17.700 | 17.668 | USD 2,438 | 17.48 |
| 2024-10-23 | BUY | 138 | 17.380 | 17.700 | 17.668 | USD 2,438 | 17.48 |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of PCRX
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-09-19 | 52,099 | 0 | 123,269 | 42.3% |
| 2025-09-18 | 43,539 | 0 | 107,413 | 40.5% |
| 2025-09-17 | 54,189 | 0 | 246,306 | 22.0% |
| 2025-09-16 | 82,421 | 0 | 239,735 | 34.4% |
| 2025-09-15 | 159,073 | 2 | 307,671 | 51.7% |
| 2025-09-12 | 205,225 | 0 | 267,650 | 76.7% |
| 2025-09-11 | 80,513 | 0 | 176,033 | 45.7% |
| 2025-09-10 | 116,502 | 0 | 171,706 | 67.8% |
| 2025-09-09 | 112,414 | 0 | 188,831 | 59.5% |
| 2025-09-08 | 105,261 | 0 | 236,751 | 44.5% |
| 2025-09-05 | 75,537 | 0 | 131,849 | 57.3% |
| 2025-09-04 | 149,745 | 7,159 | 289,312 | 51.8% |
| 2025-09-03 | 97,245 | 0 | 200,543 | 48.5% |
| 2025-09-02 | 75,560 | 0 | 288,063 | 26.2% |
| 2025-08-29 | 110,380 | 0 | 181,051 | 61.0% |
| 2025-08-28 | 205,314 | 2,000 | 326,738 | 62.8% |
| 2025-08-27 | 195,950 | 0 | 334,509 | 58.6% |
| 2025-08-26 | 80,181 | 0 | 135,869 | 59.0% |
| 2025-08-25 | 65,949 | 0 | 124,996 | 52.8% |
| 2025-08-22 | 49,762 | 0 | 102,734 | 48.4% |
| 2025-08-21 | 80,876 | 0 | 126,100 | 64.1% |
| 2025-08-20 | 56,330 | 0 | 101,290 | 55.6% |
| 2025-08-19 | 75,737 | 0 | 218,361 | 34.7% |
| 2025-08-18 | 152,697 | 0 | 401,062 | 38.1% |
| 2025-08-15 | 125,600 | 0 | 367,483 | 34.2% |
| 2025-08-14 | 93,376 | 0 | 314,283 | 29.7% |
| 2025-08-13 | 66,587 | 0 | 288,603 | 23.1% |
| 2025-08-12 | 131,601 | 17 | 215,996 | 60.9% |
| 2025-08-11 | 87,101 | 0 | 177,377 | 49.1% |
| 2025-08-08 | 318,236 | 0 | 459,607 | 69.2% |
| 2025-08-07 | 223,165 | 0 | 394,083 | 56.6% |
| 2025-08-06 | 500,520 | 0 | 674,653 | 74.2% |
| 2025-08-05 | 136,316 | 0 | 282,392 | 48.3% |
| 2025-08-04 | 240,686 | 0 | 344,051 | 70.0% |
| 2025-08-01 | 450,666 | 0 | 517,524 | 87.1% |
| 2025-07-31 | 124,402 | 0 | 322,818 | 38.5% |
| 2025-07-30 | 121,888 | 0 | 287,261 | 42.4% |
| 2025-07-29 | 44,574 | 0 | 85,432 | 52.2% |
| 2025-07-28 | 84,917 | 0 | 184,799 | 46.0% |
| 2025-07-25 | 137,007 | 43 | 238,974 | 57.3% |
| 2025-07-24 | 47,747 | 0 | 98,609 | 48.4% |
| 2025-07-23 | 48,178 | 0 | 113,468 | 42.5% |
| 2025-07-22 | 66,252 | 2,839 | 149,873 | 44.2% |
| 2025-07-21 | 111,788 | 0 | 294,458 | 38.0% |
| 2025-07-18 | 99,442 | 795 | 177,714 | 56.0% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Note: All information is provided as is without warranty and should be used for indicative purposes only.
You should independently check data before making any investment decision.
This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.